Pharma Industry News

Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds

Report from the ONE Campaign considered vaccine supply deals agreed by G20 countries and the EU

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]